Mrs Sara Jeanne Mcdole, PA-C | |
234 Maple Ave, Barrington, RI 02806-3406 | |
(401) 247-1644 | |
(401) 247-4961 |
Full Name | Mrs Sara Jeanne Mcdole |
---|---|
Gender | Female |
Speciality | Pediatrics - Adolescent Medicine |
Location | 234 Maple Ave, Barrington, Rhode Island |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1306462502 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
363A00000X | Physician Assistant | (* (Not Available)) | Secondary |
2080A0000X | Pediatrics - Adolescent Medicine | PA01233 (Rhode Island) | Primary |
Mailing Address | Practice Location Address |
---|---|
Mrs Sara Jeanne Mcdole, PA-C 225 Central St, Harrisville, RI 02830-1536 Ph: (401) 263-1829 | Mrs Sara Jeanne Mcdole, PA-C 234 Maple Ave, Barrington, RI 02806-3406 Ph: (401) 247-1644 |
News Archive
IKBFU scientists developed the composition of the capsule shell for the enzyme needed in the treatment of a hereditary disease called "phenylketonuria".
pSivida Corp., a leading drug delivery company that has developed two of the only three products approved by the FDA for the long term, sustained release delivery of drug to treat chronic back of the eye disease, today announced that enrollment has begun for a pilot study to assess the safety and efficacy of Iluvien in patients with macular edema secondary to retinal vein occlusion.
Dry eye disease (DED) is a common condition that causes discomfort, visual disturbance and potentially damaging ocular surface inflammation that greatly impacts a person's quality of life.
A gene essential to the production of pain-sensing neurons in humans has been identified by an international team of researchers co-led by the University of Cambridge. The discovery, reported today in the journal Nature Genetics, could have implications for the development of new methods of pain relief.
Ten percent of cancer patients failed to fill their initial prescriptions for oral anti-cancer drugs, according to a new study published jointly today in the Journal of Oncology Practice and American Journal of Managed Care.
› Verified 7 days ago